Anti-SLFN11 Antibody, clone 3E13 ZooMAb^® Rabbit Monoclonal

rabbit

200

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

3E13, recombinant monoclonal

recombinant, expressed in HEK 293 cells

ZooMAb^® learn more

lyophilized

calculated mol wt 102.84 kDa
observed mol wt ~100 kDa

human

antibody small pack of 25 μL

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunocytochemistry: suitable
western blot: suitable

IgG

N-terminal half

NP_001098057

Q7Z7L1

ambient

2-8℃

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Learn more about ZooMAb here.

Clone 3E13 is a ZooMAb^® rabbit recombinant monoclonal antibody that specifically detects Schlafen family member 11 (SLFN11). It targets an epitope within the N-terminal half.

His-tagged recombinant fragment corresponding to 73 amino acids from the N-terminal half of human Schlafen family member 11 (SLFN11).

Quality Control Testing

Evaluated by Western Blotting in HL-60 cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected SLFN11 in HL-60 cell lysate.

Tested applications

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected SLFN11 in HL-60 cells.

Affinity Binding Assay: A representative lot of this antibody bound recombinant SLFN11 fragment with a KD of 1.0 x 10-12 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-SLFN11, clone 3E13 ZooMAb^®, Cat. No. ZRB1405, is a recombinant Rabbit monoclonal antibody that detects Schlafen family member 11 (SLFN11) and is tested for use in Affinity Binding Assay, Immunocytochemistry, and Western Blotting.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 mg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Schlafen family member 11 (UniProt: Q7Z7L1; also known as SLFN11) is encoded by the SLFN11 gene (Gene ID: 91607) in human. SLFN11 is an inhibitor of DNA replication that promotes cell death in response to DNA damage. It is reported to block stressed replication forks by opening chromatin across replication initiation sites at stressed replication forks that leads to unwinding of DNA ahead of the minichromosome maintenance protein complex (MCM) helicase and block fork progression, ultimately leading to cell death. It is shown to act independently of ATR. SLFN11 is also reported to be a dominant determinant of sensitivity to DNA-damaging anticancer drugs. Its levels are down-regulated in a number of chemoresistant tumors. It is shown to be down-regulated in small cell lung cancer (SCLC) cells that are resistant to PARP inhibitor drugs. It exhibits a wider expression range in ovarian and colon adenocarcinoma than in their corresponding healthy tissues. Its levels are up-regulated by type I interferons and it acts as an interferon-induced antiviral protein that inhibits retrovirus protein synthesis. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1